The two active substances are antivirals that inhibit HIV reverse transcriptase through incorporation into the viral DNA, ...

It’s estimated that over 10 million people around the world develop Alzheimer’s disease annually,” according to Dr.

Doctor Jayakrishna Ambati and his research team have begun work on a new drug called K9 which could treat and prevent ...

Nucleoside reverse transcriptase inhibitors appear to be neuroprotective, thus lowering the incidence of Alzheimer dementia.

A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for ...

The use of nucleoside reverse transcriptase inhibitors, but not other HIV medicines, is linked to a reduced risk for ...

Nucleoside reverse transcriptase inhibitors (NRTIs) are used to prevent HIV and hepatitis B from replicating and spreading ...

Nucleoside reverse transcriptase inhibitors -- antiretroviral drugs approved to treat HIV and hepatitis B -- were associated ...

A new study has found that a common class of medications could dramatically decrease the risk of developing the neurodegenerative disorder.

Scientists have identified a promising new class of treatments for Alzheimer's disease, and they're already widely used to ...

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases ...

While investigating how the medicine uses the body’s immune system to ward off HIV symptoms, researchers realized that it ...